复极化后的折射性与I类抗不律性药物引起的导电减速:抗不律性和前不律性作用
P F Kirchhof1, C L Fabritz, M R Franz
1Cardiology Division, Veterans National Administration Center, Washington, DC 20422, USA.
Circulation
|July 10, 1998
概括
药物诱导的后反极化折射性 (PRR) 能够防止心室动 (VF). 然而,propafenone可以通过影响导电和波长来促进缓慢的单形心室性心力衰竭 (VT).
科学领域:
- 电子生理学 电子生理学
- 心脏药理学心脏药理学
背景情况:
- 导电阻可以是抗心律失常和前心律失常.
- 药物诱导的反极化后折射性 (PRR) 可能会预防动脉节律失常.
- 研究了propafenone和procainamide的抗心律失常和前心律失常作用.
研究的目的:
- 调查普罗帕芬和普罗卡因胺对心脏电生理学的影响.
- 为了确定这些药物的抗不律性或前不律性后果.
- 评估后反极化折射性在药物诱导的心律失常症中的作用.
主要方法:
- 使用了隔离的兰登多夫透的子心脏.
- 记录了单相动作潜力 (MAP) 和心电图.
- 在药物注射之前和之后,通过电刺激诱导了心室低心率 (VT) 和心室动 (VF).
主要成果:
- 芬和普罗卡因胺都延长了作用潜力的持续时间,并诱导了PRR.
- 普罗卡因胺减少了70%的VF诱导性,而芬消除了VF.
- 普罗帕芬显著减缓了导电和缩短了波长,导致57%的爆发刺激中引发了静脉动.
结论:
- 药物诱导的PRR有效地防止心室动 (VF).
- 尽管能预防静脉炎症,但可促进缓慢单态静脉炎症.
- 根据使用情况的导电减速和波长缩短由烯可能是VT促进的基础.
相关概念视频
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...


